The LAUREL study is a clinical research study for adults with non-muscle invasive bladder cancer (NMIBC) who need transurethral resection of bladder tumor (TURBT). The goal of the study is to find out if the study medicine is safe and does not cause too many side effects when delivered directly into the bladder. Researchers also hope to learn how the body processes the study medicine.
Study participants may be able to join the study if they meet the following requirements:
Other study requirements apply. Ask your doctor if you qualify and if the LAUREL study is a good option for you.
The study is divided into phases and periods.
The support of Patient Concierge Services (PCS) will be available to help patients with travel needs along with payment services (i.e meal reimbursements) to help reduce financial burden and logistical planning stresses.
There will be a dedicated team that provides one-on-one support for patients that are needing travel accommodations or payment services.
Participation in a clinical study is voluntary. You can ask any questions you have and may leave the study at any time, for any reason.